SebErb( Gefitinib INN 250 mg)


In stock

Categories: ,
  • Product Description:

SebErb (Gefitinib) is available as 250 mg film coated tablet for oral administration.

  • Product Features:

Product Name SebErb
Generic Name Gefitinib INN 250 mg
FDA Approved Indications SebErb (Gefitinib) is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected.
Packaging SebErb Tablet: Each commercial box contains 3×10’s tablets in Alu-Alu blister pack.
Prescribing Information SebErb
Be the first to review “SebErb( Gefitinib INN 250 mg)”

Your email address will not be published.


There are no reviews yet.

Main Menu

SebErb( Gefitinib INN 250 mg)


Add to Cart